Glucotrack Stock Net Income
| GCTK Stock | USD 7.84 1.63 26.25% |
GlucoTrack's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting GlucoTrack Stock price.
| Last Reported | Projected for Next Year | ||
| Net Loss | -22.6 M | -21.5 M | |
| Net Loss | -5.1 M | -5.4 M | |
| Net Loss | -22.6 M | -21.5 M | |
| Net Income Per Share | 60.76 | 63.80 | |
| Net Income Per E B T | 0.90 | 0.79 |
GlucoTrack | Net Income | Build AI portfolio with GlucoTrack Stock |
GlucoTrack Company Net Income Analysis
GlucoTrack's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current GlucoTrack Net Income | (22.6 M) |
Most of GlucoTrack's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GlucoTrack is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
GlucoTrack Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for GlucoTrack is extremely important. It helps to project a fair market value of GlucoTrack Stock properly, considering its historical fundamentals such as Net Income. Since GlucoTrack's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GlucoTrack's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GlucoTrack's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
GlucoTrack Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, GlucoTrack reported net income of (22.6 Million). This is 106.62% lower than that of the Health Care Equipment & Supplies sector and 122.68% lower than that of the Health Care industry. The net income for all United States stocks is 103.96% higher than that of the company.
GlucoTrack Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GlucoTrack's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GlucoTrack could also be used in its relative valuation, which is a method of valuing GlucoTrack by comparing valuation metrics of similar companies.GlucoTrack is currently under evaluation in net income category among its peers.
GlucoTrack ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GlucoTrack's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GlucoTrack's managers, analysts, and investors.Environmental | Governance | Social |
GlucoTrack Institutional Holders
Institutional Holdings refers to the ownership stake in GlucoTrack that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of GlucoTrack's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing GlucoTrack's value.| Shares | Virtu Financial Llc | 2025-03-31 | 51.2 K | Hrt Financial Llc | 2025-03-31 | 35.2 K | Xtx Topco Ltd | 2025-03-31 | 13.8 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 25.0 | Sbi Securities Co Ltd | 2025-03-31 | 18.0 | Bank Of America Corp | 2025-03-31 | 4.0 | Cetera Investment Advisers | 2024-12-31 | 0.0 | Alerus Financial Na | 2024-12-31 | 0.0 | Ubs Group Ag | 2024-12-31 | 0.0 |
GlucoTrack Fundamentals
| Return On Equity | -6.94 | ||||
| Return On Asset | -1.61 | ||||
| Current Valuation | (5.88 M) | ||||
| Shares Outstanding | 567.46 K | ||||
| Shares Owned By Insiders | 8.84 % | ||||
| Shares Owned By Institutions | 1.27 % | ||||
| Number Of Shares Shorted | 1.47 M | ||||
| Price To Book | 0.41 X | ||||
| Gross Profit | (20 K) | ||||
| EBITDA | (21.98 M) | ||||
| Net Income | (22.6 M) | ||||
| Cash And Equivalents | 3.85 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 267 K | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 4.52 X | ||||
| Book Value Per Share | 17.02 X | ||||
| Cash Flow From Operations | (12.49 M) | ||||
| Short Ratio | 0.33 X | ||||
| Earnings Per Share | (3,443) X | ||||
| Number Of Employees | 11 | ||||
| Beta | -0.19 | ||||
| Market Capitalization | 2.96 M | ||||
| Total Asset | 5.93 M | ||||
| Retained Earnings | (132.45 M) | ||||
| Working Capital | 4.49 M | ||||
| Net Asset | 5.93 M |
About GlucoTrack Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GlucoTrack's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GlucoTrack using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GlucoTrack based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out GlucoTrack Piotroski F Score and GlucoTrack Altman Z Score analysis. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.